Clinical Trial: Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: PCOS(Insulin Resistant)
Study Type: INTERVENTIONAL
Official Title: Effect of Pioglitazone on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS in Comparison to Metformin
Brief Summary:
Women with PCOS with HOMA-IR >2 fulfilling inclusion and exclusion criteria are randomly allocated into two groups: group A: pioglitazone 30 mg once daily and group B: Metformin 500 thrice daily for 3 months.Each group contains 30 participants.Outcome variables are measured after 3 months.
Read more